The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries

BACKGROUND AND AIMS: We assessed the clinical and economic impact of direct‐acting antiviral (DAA) therapy for hepatitis C virus (HCV) in England, Italy, Romania and Spain. METHODS: An HCV progression Markov model was developed considering DAA eligibility and population data during the years 2015‐20...

Descripción completa

Detalles Bibliográficos
Autores principales: Mennini, Francesco S., Marcellusi, Andrea, Robbins Scott, Sarah, Montilla, Simona, Craxi, Antonio, Buti, Maria, Gheorghe, Liana, Ryder, Stephen, Kondili, Loreta A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Liver Disease and Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248004/
https://www.ncbi.nlm.nih.gov/pubmed/33529499
http://dx.doi.org/10.1111/liv.14808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248004/
https://www.ncbi.nlm.nih.gov/pubmed/33529499
http://dx.doi.org/10.1111/liv.14808

Ejemplares similares